Trade with Eva: Analytics in action >>
Showing posts with label GDRX. Show all posts
Showing posts with label GDRX. Show all posts

Friday, December 1, 2023

Insider Trading Fri 12/1/23

Notable purchases -- JANA Partners adds to MRCY; notable sales -- President/COO active in FRT

Buyers:

  • AGL Director bought 22,300 shares at $11.12 - $11.30 worth ~$250K.
  • BMY Chief Executive Officer bought 3,071 shares at $48.86 worth ~$150K.
  • GDRX Interim Chief Executive Officer bought 30,505 shares at $5.82 - $6.00 worth ~$180K.
  • MRCY 10% owner JANA Partners bought 245,964 shares at $33.02 - $34.22 worth more than $8.2 mln.
  • OUST Director bought 10,000 shares at $5.22 - $5.25 worth ~$52K.
  • RMAX 10% owner bought 36,687 shares at $8.78 - $9.00 worth ~$325K.
  • RNGR Chief Executive Officer and Chief Financial Officer bought a total of 25,000 shares at $9.68 - $9.99 worth ~$247K.
  • STAA 10% owner Broadwood Partners bought 434,991 shares at $30.84 - $32.11 worth approx. $13.7 mln.
  • TTSH 10% owner bought 96,317 shares at $6.48 - $6.61 worth ~$632K.

Sellers:

  • CTGO Director sold 30,000 shares at $22.81 - $23.06 worth more than $687K.
  • EWBC Vice Chairman sold 12,000 shares at a weighted average price of $63.294 worth ~$759K.
  • FRT President and COO sold 4,870 shares at $94.86 worth ~$462K.

Tuesday, November 8, 2022

GoodRx (GDRX) reported earnings on Tue 8 Nov 22 (a/h)

 ** charts before earnings **


** charts after earnings **
 

GoodRx beats by $0.03, beats on revs; guides Q4 revs below consensus 

  • Reports Q3 (Sep) earnings of $0.07 per share, excluding non-recurring items, $0.03 better than the S&P Capital IQ Consensus of $0.04; revenues fell 4.0% year/year to $187.32 mln vs the $185.01 mln S&P Capital IQ Consensus.
  • Co issues downside guidance for Q4, sees Q4 revs of $175-$180 mln vs. $204.86 mln S&P Capital IQ Consensus.
    • "Our focus on Adjusted EBITDA growth, margin improvement, and cash conversion remain our top priorities," said Karsten Voermann, Chief Financial Officer. "We are guiding to fourth quarter total revenue in the range of $175 million to $180 million, which includes a combined $45 million to $50 million estimated impact to prescription transactions revenue related to the previously disclosed grocer issue and our continued consumer engagement efforts. We expect Adjusted EBITDA Margins in the low-to-mid-twenty-percent range."

Monday, November 7, 2022

Earnings this week : Nov 7 - 11, 22 (wk 45)

Monday (Nov 7)
  • Morning:  AMG BLDP BNTX WHD CHH CRON DK WTRG FNV HAE HLIO DINO HEP NI NRG PLTR RBA FOUR THS VTRS
  • Afternoon: ME TWOU AAON ACCO ATVI ADTN LNT AEL AMWL ASH BNFT BHF BWXT CBT CERT DHT FANG DOCN DIOD EHTH FN FGEN FIVN FLGT GRPN HIMS ICUI IFF LGND LPSN LYFT MTW DOOR MLNK MOS MWA NSTG NFE OSH PACB PRDO PRIM QTWO QGEN ROVR SANM SWAV SEDG TTWO TASK TDC TRIP UIS VECO VNOM WELL XNCR YMAB
Tuesday (Nov 8)
  • Morning: ACRS AHCO BSY BLDR CG CLVT CNHI CEG COTY CYXT DBD DD ELAN EXK EVBG EVRI EXPD FA GFS HAIN HSKA IGT RIDE LITE MNKD NEO NXST NWN NCLH NOVT PKI PRGO PLNT PLTK PRTY RCM RETA REYN SAGE SCSC SSP SQSP STVN SPWR SHO SKIN TAC TGI
  • Afternoon:  DDD ABCL AFRM AKAM ALRM BIRD AMC DOX AMRS ANGI ARLO ARRY AXON BLNK  CLNE CRCT DAR DV EBS ENV EOLS FNF FLYW GMED GDRX GO GXO HALO HCAT HRTX ICHR IOSP INO IAC NVTA JKHY LMND LFST RAMP LCID MASI MRTX MO CARG DN MRC NTRA NHI NEWR NWSA KIND NOG NLOK NVAX OXY OPK OSUR PLUG PRI PRA PUBM SEER SILK SRC SFM SUPN SG TWO UPST VSAT WTI DIS XENE ZD
Wednesday (Nov 9)
  • Morning:  DIBS ALE BGNE BHG CGC CPRI CEVA GIB DHI EBIX AG FVRR HBI HR HL HGV IMXI IONS KRNT LTH MIDD NOMD OLPX PAR PFGC PERI RDNT RSKD RBLX RCI SEAS SPTN STWD STER TBLA TRP TGNA TTD COCO TPG VCEL VERX WD WEN WWW
  • Afternoon:  ACVA APP ATO BGS BYND BMBL CELH CDE CPNG DM APPS BROS EGIO ENS FICO FORG G GDOT IPAR JXN JAMF JAZZ KGC LNW MGNI MFC MQ NVTS NUVA OLO PAAS PAY PAYO PETQ PLBY PRPL RXT RDFN RPAY RNG RIVN STE STKL TTGT TTEK COOK TTEC U VZIO VUZI WYNN ZIMV ZIP
Thursday (Nov 10)
  • Morning: MT AZN AZUL BDX BAM CAE DGII EPC GENI HIMX IAA KELYA SWIM NABL EYE NICE NIO PSFE PGTI PRMW RL RBC SBH SHCR SIX SSYS SLVM TPR TDG USFD UTZ WRBY WRK WE WIX YETI
  • Afternoon:  AGTI LFG BBDC BZH CDRE COMP CCSI LAW DOCS DUOL EDR EXFY FIGS FLO INDI LZ MCW MTTR POSH RYAN SWIR SMRT TOST VTEX
Friday (Nov 11)  
  • Morning:  AQN

Monday, August 8, 2022

GoodRx (GDRX) reported earnings on Mon 8 Aug 22 (a/h)

 ** charts before earnings **




** charts 3 days after earnings **



GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.10, delivering a surprise of 25%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

GoodRx Holdings, Inc. , which belongs to the Zacks Medical Services industry, posted revenues of $191.8 million for the quarter ended June 2022, surpassing the Zacks Consensus Estimate by 4.33%. This compares to year-ago revenues of $176.64 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

GoodRx Holdings, Inc. Shares have lost about 78.4% since the beginning of the year versus the S&P 500's decline of -13%.

Earnings this week : Aug 8 - 12, 22 (wk 32)

Monday (Aug 8)
  • Morning:  GOLD BNTX D ELAN ENR HSKA DINO MNDY PLTR RDWR RETA TGNA THS TSN VTRS
  • Afternoon: TXG ME DDD AAON ACAD ACCO ACM BIRD AEL AIG AZPN AVLR BLNK BCOR BWXT CBT CARG DM APPS DOCN EGIO EHTH ESE FGEN FRPT GBT GDRX GRPN HLIO HIMS HBM ICUI INSG IFF LMND LGND LPSN VAC DOOR MESA MRC NCMI NHI NWSA NE NVAX OKE OPRT PRDO PRAA PRI PRIM PFG PRA PUBM QLYS SWAV SDC SWCH TTWO SKT TASK TREX UPST VXRT VECO VLDR VSAT VVNT VRM WPRT YMAB
Tuesday (Aug 9)
  • Morning: MASS AHCO AMRS ARMK ATC AVNS BHC BSY CPRI CRNC CEVA ECOM CLVT CRON DIN EBIX EMR EXK EVGO GFS HR HRTX HGV H IAA INGR ITCI IONS KYMR LPX NEO NCLH NOVT OLPX PAR PRGO PLNT RDNT RL REYN SAVE STER SNCY SYY TNC SKIN TPG TDG VERX SEAT WMG
  • Afternoon:  ABCL AKAM ALRM ANGI ARLO ARRY ATCO AXON AZTA BBDC BLI BE CG CELH CERT CCXI COIN CCSI CRCT DAR DLB DOMA EVBG EXEL FLYW GO HRB HALO ICHR INO IPAR IAC NVTA JXN LFST LNW MGNI MASI MAXR MLNK MODN ONTO OSUR PETQ PLBY PLUG PRPL RXT RRR RPAY RBLX SAIL SEER LRN SMCI SG TBLA REAL TTD TTEC U VIR VUZI WELL WISH WK WYNN ZD
Wednesday (Aug 10)
  • Morning:  DIBS BLDP BHG CAE CYBR FOXA HAE IS JACK KRNT LTH NOMD RSKD SHCR COCO WEN WIX WWW
  • Afternoon:  AKA ACVA AOSL APP AVT BMBL CACI CPNG DHT BROS ENS FLNC FNV MFC MQ MTTR PAAS RRGB SONO STAA COOK VZIO DIS ZIMV
Thursday (Aug 11)
  • Morning: AER AIT AZUL BAM GOOS CAH CYXT HBI HIMX HLLY KELYA SWIM NABL EYE PRMW SIX DTC SGHC SLVM USFD UTZ WKME WRBY
  • Afternoon:  ATGE AQN CDRE LAW FLO FORG ILMN INDI LZ LYLT OLO PAYO POSH RMD RIVN RYAN SWIR SMRT TOST VIAV VTEX WPM UP
Friday (Aug 12)  
  • Morning:  BR SPB

Saturday, May 14, 2022

This week's biggest % winners & losers : May 9 - 13, 22 (wk 19)

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers
  • Healthcare: BHVN (140.96 +56.19%), ITCI (58.96 +27.62%), FOLD (7.56 +20.57%), EOLS (13.16 +19.64%), FGEN (9.92 +17.95%), OPK (3.00 +14.5%), TCDA (9.13 +14.27%), PRGO (36.89 +13.56%)
  • Industrials: RBA (61.97 +18.44%), TREX (62.57 +12.8%), ENR (33.27 +10.97%)
  • Consumer Discretionary: HRB (32.29 +27.56%), NDLS (6.49 +16.94%), MBUU (59.81 +15.26%)
  • Information Technology: APPN (57 +19.95%)
  • Consumer Staples: THS (38.85 +27.21%), NOMD (21 +18.98%), BRFS (2.74 +14.64%)
This week's top % losers
  • Healthcare: TXMD (3.07 -60.01%), BHC (10.86 -32.29%), EVLO (1.67 -32.11%), GDRX(8.90  -30.14%), SIBN (12.46 -27.88%), INO (1.99 -25.38%), FLDM (2.21 -25.08%), CRBP (0.22 -24.61%), RYTM (3.27 -23.6%), FIXX (1.43 -23.53%)
  • Industrials: KRNT (44.51 -30.66%)
  • Consumer Discretionary: PRTY (1.43 -53.43%), TUP (7.28 -26.74%), EYE (26.13 -26.31%)
  • Information Technology: DM (1.89 -52.63%), U (39.10  -31.81), AVYA (6.41 -26.72%)
  • Energy:  MTRX (5.01 -23.39%)

Monday, May 9, 2022

GoodRx (GDRX) reported earnings on Mon 9 May 22 (a/h)

 ** charts before earnings **



** charts after earnings **

 


GoodRx beats by $0.02, beats on revs; guides Q2 revs below consensus; unlikely to achieve prior FY22 guidance 
  • Reports Q1 (Mar) earnings of $0.10 per share, excluding non-recurring items, $0.02 better than the S&P Capital IQ Consensus of $0.08; revenues rose 26.7% year/year to $203.3 mln vs the $200.61 mln S&P Capital IQ Consensus.
    • 6.4 mln monthly active users, +12% yr/yr. 
  • Co issues downside guidance for Q2, sees Q2 revs of ~$190 mln vs. $216.02 mln S&P Capital IQ Consensus.
  • At this time, we believe it is unlikely we will be able to achieve the FY 2022 guidance we provided on our fourth quarter earnings call. We will not be providing full year expectations at this time as the full year impact of the grocer issue is difficult to estimate because there are several variables including, among others, eventual consumer pricing and returning usage levels that have yet to be determined.

Earnings this week : May 9 - 13, 22 (wk 19)

Monday (May 9)
  • Morning:  ACM AZUL BNTX CLVT COTY DUK ELAN ENR HSKA DINO HGV HEP JLL RIDE MAC MSGE PLTR RCM RDNT TGNA TWKS THS TSN VTRS WOW
  • Afternoon: DDD AMC AMWL ANGI AZTA BLI BLNK BHF BWXT CARG DHT DNB EQH ESE EVBG FGEN GDRX GRPN HLIO HRTX HI HIMS HBM ICUI IAC IFF JRVR FROG LPSN MGY MAXR MESA MCHP MRC NCMI NHI NVAX OPK OPRT PLUG PRAA PRIM PRA PUBM RNG RBA ROVR SWAV SPG SDC SU SUPN TASK TDUP TREX UNVR UPST VVV VECO VRM XPO YMAB ZNGA
Tuesday (May 10)
  • Morning: MASS ACRS AHCO ALGM AMRS ARMK AVYA AZEK BHC BSY BCO BLDR CRNC CEVA CHH CRON XRAY DM DBD DSEY EBIX EPC ENOV EVRI FOXA HAE HL H IAA IIVI IGT ITCI KNBE LCII LI MBUU MIDD EYE NXST NCLH NOVT PTON PLNT RETA REYN STER STVN SYY TTGT TPG TDG VERX WMG
  • During Market Hours: ENTA
  • Afternoon:  EGHT AKA ABCL BIRD ARLO ARRY AXON BOOT BRP ELY CELH COIN COLL CRCT CUTR DAR MSP DV DOUG EA EOLS EXEL FNF FLYW GFS GMED GOCO GO GRWG HALO HCAT ICHR INO IPAR JXN JAMF KGC LNW MTTR MODN NSTG OXY OLO OSUR PLBY PRPL RXT RPAY RBLX RKT SCSC SOFI SWCH SKIN REAL TTD U VUZI WELL WES WYNN YELL ZETA ZD
Wednesday (May 11)
  • Morning:  ATC FVRR KRNT DNUT LTH NOMD OLPX PFGC PRGO SLVM WEN WWW YETI
  • Afternoon:  DIBS ACVA DOX APP ATCO BYND BMBL CPA CPNG BROS FLNC MFC MQ PAAS RIVN SMRT SONO STE SLF COOK DIS ZIP
Thursday (May 12)
  • Morning: CAMT CYBR CYXT DAVA GENI HIMX HLLY IS KELYA NABL NICE NVMI PGTI PRMW SHCR SIX DTC SQSP TPR TNK USFD UTZ
  • Afternoon:  AFRM AQN BLND BRLT COMP LAW DUOL FIGS HRT INDI LZ MLNK MSI NVTS NEWR PAYO POSH TBLA TOST VZIO VTEX UP
Friday (May 13)  
  • Morning:  PLXP

Monday, February 28, 2022

GoodRx (GDRX) reported earnings on Mon 28 Feb 22 (a/h)

 ** charts after earnings **



 
 


GoodRx misses by $0.01, misses on revs; guides Q1 revs below consensus; guides FY22 revs below consensus
  • Reports Q4 (Dec) earnings of $0.09 per share, excluding non-recurring items, $0.01 worse than the S&P Capital IQ Consensus of $0.10; revenues rose 39.0% year/year to $213.3 mln vs the $217.51 mln S&P Capital IQ Consensus.
    • Monthly active consumers +14% yr/yr to 6.4 mln.
    • Fourth quarter Prescription Transactions Revenue grew 21% year-over-year to $158.8 million.
    • Fourth quarter Subscription Revenue grew 79% year-over-year to $17.4 million.
  • Co issues downside guidance for Q1, sees Q1 revs of ~$200 mln vs. $227.44 mln S&P Capital IQ Consensus.
  • Co issues downside guidance for FY22, sees FY22 revs growth of ~23%, which translates to ~$916.8 mln vs. $1.02 bln S&P Capital IQ Consensus.

Earnings this week : Feb 28 - Mar 4, 2022 (wk 9)

Monday (Feb 28)
  • Morning:  ASTE WHD CWEN XRAY DEA HSKA HNI ITRI JLL RIDE EYE NLSN RETA TGNA VTRS
  • Afternoon: DDD AAON ACHC ACAD AMBA BIGC BLNK DAR ENDP FATE FGEN FRPT GDRX GRPN HLIO HRTX HPQ JRVR LCID MRTX NKTR NVAX OSH OKE PDCE PRAA PRIM PGNY PUBM SAIL SBAC SEER SDC SRI SUPN TASK TREX VLDR VRM WDAY ZM
Tuesday (Mar 1)
  • Morning: GOLF ADT AMRN AMRS APG AZO BIDU BMO BNS BSY BLDR CLVT DPZ EHTH EPZM EVRI FSS HTA HGV HZNP HRL TWNK TILE IGT ITCI SJM KSS KTB MANU MLCO NFE NOVT PRGO RDNT SE FOUR SHC TGT TMX TRS WEN XHR
  • Afternoon:  DIBS AKA AMC ARLO BGS BNFT CDLX CELH CERT CCXI DOMO BROS FSLR GO GRWG HCAT HPE INO INSG IPAR JAMF JAZZ NSTG JWN PETQ PLBY RGNX RPAY ROST CRM SRPT SGMS SOFI TTEC URBN VUZI WISH WW ZIP
Wednesday (Mar 2)
  • Morning:  ANF DIN DLTR DCI DY HAYW PDCO STER
  • Afternoon:  AEO PLAN BOX AI CHPT CPNG DSGX FLYW GEF GSM JXN NTNX OKTA PSTG RSI SGFY SNOW SPLK VEEV VSCO ZUO
Thursday (Mar 3)
  • Morning: BBY BIG BILI BJ BF.B BURL CNQ CPG GMS GOGO HLLY KR MTLS TTC TD UTZ WB
  • Afternoon:  AVAV AQN AVGO COO COST DUOL ESTC EOLS FNKO GPS GDYN MRVL NCMI PAYO PBYI SG  SWBI VZIO
Friday (Mar 4)  
  • Morning:  HIBB

Tuesday, November 17, 2020

Amazon (AMZN) launches digital pharmacy

  • That launch has been expected for some time, although the exact timing was uncertain. Well, that time has arrived, as Amazon's pharmacy services are now available in 45 states, with the other five states expected to be added in the future.
  • This expansion puts the e-commerce company into more direct competition with pharmacy giants, such as CVS and Walgreens Boots.



 

 


(Bloomberg)—Amazon.com Inc. unveiled its biggest push into selling prescription drugs with the launch of a digital pharmacy and discounts for paying U.S. Prime members that sent shock waves through shares of drugstore chains and distributors.

The e-commerce giant on Tuesday unveiled Amazon Pharmacy, a section of its retail website and mobile application that lets people order medication. Shoppers can pay using their health insurance. Prime members who don’t use their insurance are eligible for discounts on generic and brand-name drugs on Amazon’s site or at about 50,000 participating pharmacies.

Amazon’s new offering comes more than two years after its $753 million acquisition of PillPack, an online pharmacy known for organizing prescriptions into packets. This expansion puts the Seattle-based e-commerce company into more direct competition with pharmacy giants CVS Health Corp. and Walgreens Boots Alliance Inc., the two largest chains in the U.S.

The move also helps Amazon compete with Walmart Inc. and other big-box stores that already sell prescription drugs.

Analysts have long expected Amazon to dive deeper into health care in a bet the company can bring its digital real estate and logistical prowess to bear on a roughly $4 trillion industry in the U.S. with a reputation for inefficiency. The company rattled drug retailers with its PillPack acquisition, but Amazon has been slow to integrate the online pharmacy startup into its offerings.

The announcement Tuesday marks the first time that shoppers can order prescription drugs directly on Amazon. Previously, they were redirected to PillPack’s website. An integrated pharmacy removes one of the few gaps in Amazon’s offerings compared with major big box and grocery rivals, some of whom have long filled shoppers’ prescriptions in the same stores where they sold flat-screen televisions or cans of soup.

The discounts are a clear play for people who pay for their medications with cash, whether they are uninsured or are looking to save money. Strong demand for transparency and better deals have helped fuel the rise of discount card programs like GoodRx Holdings Inc. Amazon will display both the price when using insurance and the price without. Infusing transparency into a system that has been frustratingly opaque for consumers could alter the supply chain.

Amazon’s entry into a market doesn’t guarantee its dominance. Drugstores have long insisted that patients prefer to talk to their pharmacist at the counter, an experience Amazon will try to recreate digitally.

Amazon Chief Executive Officer Jeff Bezos has positioned Prime, Amazon’s paid membership program, at the center of the company’s efforts to create loyal customers. What was originally an unlimited shipping program has grown in recent years to include video streaming, games and digital storage, and discounts at Amazon-owned Whole Foods Market.